CFC Planning Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
1,659
+1
+0.1% +$1.02K 1.16% 32
2026
Q1
$1.53M Buy
1,658
+402
+32% +$408K 1.09% 31
2025
Q4
$1.35M Buy
1,256
+27
+2% +$25.8K 1.03% 31
2025
Q3
$938K Buy
1,229
+20
+2% +$14.9K 0.77% 31
2025
Q2
$943K Buy
1,209
+1
+0.1% +$777 0.89% 33
2025
Q1
$998K Buy
1,208
+59
+5% +$49.1K 1.07% 33
2024
Q4
$888K Buy
+1,149
New +$951K 0.95% 33

Other funds holding LLY

CFC Planning Company's LLY Position: Q2 2026 in Review

CFC Planning Company increased its Eli Lilly (LLY) stake by 0.06% in Q2 2026, buying an estimated $1.02K and bringing the position to 1,659 shares worth $1.99M. The position accounts for 1.16% of the portfolio, ranked #32.

CFC Planning Company first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CFC Planning Company held 1,659 shares of Eli Lilly worth $1.99M as of Q2 2026.
  • CFC Planning Company bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 1.16% of CFC Planning Company's portfolio in Q2 2026, its #32 holding.
  • CFC Planning Company first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CFC Planning Company's 13F filing for Q2 2026, filed 5 Aug 2026.